Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7076
Rank
A$0.91 B
Marketcap
A$26.26
Share price
-0.91%
Change (1 day)
-48.33%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$0.10 Billion

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total liabilities are A$0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Avalon Pharma (Middle East Pharmaceutical) - Total liabilities on balance sheet (from 2023 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$73.01 M7.45%
2024-12-31A$67.94 M18.48%
2023-12-31A$57.34 M